Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-30

Clinical Trial Update: Tranexamic Acid Dosing for Total Joint Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on tranexamic acid dosing for total joint arthroplasty (hip and knee arthropathy) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Columbia University | Conditions: Arthropathy of Hip, Arthropathy of Knee | Phase 4 | Status: COMPLETED | Results posted: 2020-10-30